CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation, a manufacturer of medical devices and related
software solutions, announced today that it has received 510(k)
clearance from the U.S. Food and Drug Administration to market and begin
U.S. distribution of the new fully automatic version of the ZOLL
AED Plus®.

“Like the semiautomatic AED Plus, the fully automatic version guides
rescuers through the complete Chain of Survival, helping all sudden
cardiac arrest victims, not just those who need a shock”

This marks the first time Real
CPR Help®, ZOLL’s proprietary feedback technology, is
available to rescuers who prefer a fully automatic AED. Until now, there
was no fully automatic AED in the U.S. market that could see chest
compressions and guide rescuers to the proper depth and rate of chest
compressions. This feedback technology helps rescuers provide
high-quality manual CPR with real-time audible and visual feedback to
help them achieve the proper depth and rate of CPR chest compressions.

The new fully automatic unit provides all the same Full-Rescue features
and benefits as the semiautomatic version of the AED Plus except that a
shock is delivered automatically if one is advised. Shortly after
determining that a shock is needed and warning rescuers to stay clear,
the Fully Automatic AED Plus delivers the shock automatically—without
requiring the rescuer push the Shock button.

Research shows that safety is not compromised when rescuers use a fully
automatic rather than a semiautomatic AED.1 On initial
power-up, the Fully Automatic AED Plus will prompt “Automatic
Defibrillator” to alert the user to the type of AED. Once the heart
analysis begins and the Fully Automatic AED Plus prompts “Don’t Touch
Patent,” if a shock is needed, it will be delivered after a brief verbal
countdown. Typically a shock is delivered within 14 seconds of initial
analysis, if the presenting rhythm is shockable.

“Like the semiautomatic AED Plus, the fully automatic version guides
rescuers through the complete Chain of Survival, helping all sudden
cardiac arrest victims, not just those who need a shock,” said Jonathan
A. Rennert, President of ZOLL. “ZOLL’s Real CPR Help has been
demonstrated to effectively help guide rescuers to the correct depth and
rate of chest compressions with the goal of improving survival from
sudden cardiac arrests.”2

About Sudden Cardiac Arrest

SCA, an abrupt disruption of the heart’s function, which causes a lack
of blood flow to vital organs, claims more than one million lives
globally each year. It is the leading cause of unexpected death in the
world and strikes without warning. Survival is poor in most communities
at less than eight percent and improvements in resuscitation practices
could save as many as half of these victims.

About ZOLL Medical Corporation

ZOLL Medical Corporation, an Asahi Kasei Group company, develops and
markets medical devices and software solutions that help advance
emergency care and save lives, while increasing clinical and operational
efficiencies. With products for defibrillation and monitoring,
circulation and CPR feedback, data management, fluid resuscitation, and
therapeutic temperature management, ZOLL provides a comprehensive set of
technologies that help clinicians, EMS and fire professionals, and lay
rescuers treat victims needing resuscitation and critical care. For more
information, visit www.zoll.com.

About Asahi Kasei

The Asahi Kasei Group is a diversified group of companies led by holding
company Asahi Kasei Corp., with operations in the chemicals and fibers,
homes and construction materials, electronics, and health care business
sectors. Its health care operations include devices and systems for
critical care, dialysis, therapeutic apheresis, transfusion, and
manufacture of biotherapeutics, as well as pharmaceuticals, diagnostic
reagents, and nutritional products. With more than 25,000 employees
around the world, the Asahi Kasei Group serves customers in more than
100 countries. For more information, visit www.asahi-kasei.co.jp/asahi/en/.

Contacts

Recent Stories

CHELMSFORD, Mass.--(EON: Enhanced Online News)--ZOLL® Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that as a “Proud Supporter” of the TORON... more »

CHELMSFORD, Mass.--(EON: Enhanced Online News)--ZOLL® Medical Corporation, a manufacturer of medical devices and related software solutions, announced today its support for a landmark report releas... more »